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HIV and Cocaine Impact Glial 
Metabolism: Energy Sensor AMP-
activated protein kinase Role in 
Mitochondrial Biogenesis and 
Epigenetic Remodeling
Thangavel Samikkannu, Venkata S. R. Atluri & Madhavan P. N. Nair
HIV infection and cocaine use have been identified as risk factors for triggering neuronal dysfunction. 
In the central nervous system (CNS), energy resource and metabolic function are regulated by 
astroglia. Glia is the major reservoir of HIV infection and disease progression in CNS. However, the 
role of cocaine in accelerating HIV associated energy deficit and its impact on neuronal dysfunction 
has not been elucidated yet. The aim of this study is to elucidate the molecular mechanism of HIV 
associated neuropathogenesis in cocaine abuse and how it accelerates the energy sensor AMPKs and 
its subsequent effect on mitochondrial oxidative phosphorylation (OXPHOS), BRSKs, CDC25B/C, MAP/
Tau, Wee1 and epigenetics remodeling complex SWI/SNF. Results showed that cocaine exposure during 
HIV infection significantly increased the level of p24, reactive oxygen species (ROS), ATP-utilization and 
upregulated energy sensor AMPKs, CDC25B/C, MAP/Tau and Wee1 protein expression. Increased ROS 
production subsequently inhibits OCR/ECAR ratio and OXPHOS, and eventually upregulate epigenetics 
remodeling complex SWI/SNF in CHME-5 cells. These results suggest that HIV infection induced 
energy deficit and metabolic dysfunction is accelerated by cocaine inducing energy sensor AMPKs, 
mitochondrial biogenesis and chromatin remodeling complex SWI/SNF activation, which may lead to 
neuroAIDS disease progression.
HIV infection is known to target microglia, and subsequently impact astrocytes and neurons in the central nerv-
ous system (CNS) dysfunction1,2. Illicit drugs including cocaine are significant risk factor for HIV infection and 
AIDS disease progression3–5. Cocaine abuse can lead to the development of neuropathogenesis by altering neu-
rotransmitter systems in the brain6 and affecting glial function7–9. Glial cells (astrocytes, oligodendrocytes and 
microglia) play essential roles in the supply of energy metabolites for synaptic function, neuronal polarity, axons 
and dendritic formation10,11. HIV infection and cocaine use are known to affect neuronal function, which are 
mediated by glial cells1,2. Studies have shown that HIV-1 envelop glycoprotein 120 (gp120) is predominantly 
found in HIV positive postmortem brains and it is required for viral entry, facilitating the viral replication and 
disease progression in CNS12,13.
Energy source of intracellular ATP depletion known to threaten cellular homeostasis and integrity. Impaired 
energy metabolism may trigger pro-apoptotic signaling (programmed cell death), oxidative damage, exci-
totoxicity and impede mitochondrial damage14. Oxidative stress induced ROS production ultimately inhib-
its supply of energy sources and persuaded neuronal impairment is mediated by energy sensor 5′ adenosine 
monophosphate-activated protein kinase (AMPK)15. The AMPKs (an energy metabolism marker) is pivotal reg-
ulator of cellular function and it plays a wide role as a fuel sensor of cells or master switch of metabolic pathways16. 
AMPK is a heterotrimeric Ser/Thr protein kinase, consisting of a catalytic α subunit and two regulatory β and γ 
subunits17,18, It is predominantly expressed in most mammalian tissues and cell types, including CNS, where it is 
believed to play a critical role including energy consumption, glucose deprivation, and release of hormones and 
Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, 
Florida International University, Miami, Florida 33199, USA. Correspondence and requests for materials should be 
addressed to T.S. (email: nairm@fiu.edu) or M.P.N.N. (email: sthangav@fiu.edu)
received: 13 June 2016
Accepted: 27 July 2016
Published: 18 August 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:31784 | DOI: 10.1038/srep31784
inflammatory cytokines19,20. Furthermore, the AMPK-related kinase family of total 12 kinases has been identified 
including brain-specific serine/threonine kinases (BRSK1), (BRSK2), nuclear AMPK-related kinases novel (nua) 
kinase family 1 (NUAK1), and sucrose non fermenting AMPK-related kinase (SNARK)/NUAK2. The BRSK1/2 
(also named SAD-B/A) and SNARK proteins are closely associated with energy metabolism21. The BRSKs are 
highly expressed in mammalian forebrain, present in hippocampal neurons and play a role in neurotransmission, 
and synaptic vesicle distribution, and development of normal synapses22. Both BRSK1 and BRSK2 phosphoryl-
ate microtubule-associated proteins (MAP)/Tau that regulate microtubule stability23. Furthermore, BRSKs act 
as a checkpoint kinase, because they phosphorylate Wee1 and cell division cycle 25 B and C (CDC25B/C) and 
regulate neuronal polarization24. NUAK2 is also called SNF1/AMPK-related kinase (SNARK) and this SNF1 is 
the yeast homologue of AMPK, which is a key regulator of cellular energy homeostasis and play a major role in 
switch/sucrose nonfermentable (SWI/SNF) chromatin remodeling complex. This SNF1/SWI complex contains 
either ATPase Brm or Brg1 and Bmi-1, and all of them play important role in neural development18,25 as well as 
HIV infection and disease progression26. Recent studies demonstrated that the Brg-1, a cyclin dependent kinase 
5 (CDK5) implicate neuronal impairments including plasticity and memory dysfunction27. Also, the energy for 
SNF/SWI-mediated epigenetics remodeling is transduced by the catalytic subunit, Brm or Brg1, both of which 
have DNA-dependent ATPase activity28. In addition, this SNF/SWI complex is a CDK5 cell cycle protein and it 
may play a role in energy deficit leading to cell cycle arrest.
Overall, recent experimental evidence suggests that energy deficit lead to an important regulatory element 
in drug addiction and also in the development of neurodegenerative diseases29,30. Since glia are the major source 
of energy storage, they compensate the energy loss exporting lactate as an energy source that can be utilized by 
neurons and maintain cellular function and protective mechanisms31,32. Recent studies have demonstrated that 
cocaine affects glucose metabolism and subsequently impact various regions of the brain33. Clinical observa-
tions suggest that the cocaine abuser as well as patients with severe progression of HIV infection may present 
with energy consumption and metabolic deficits resulting in neuronal impairment. The role of energy sensor 
AMPKs mediated activation of BRSKs and SNARK proteins leading to metabolic deficit have not been studied 
yet with respect to the combine effect of cocaine and HIV infection. Furthermore, how HIV-1 and cocaine impact 
mitochondrial biogenesis in ATP utilization, oxygen consumption rate (OCR) and the secretion of extracellular 
acidification rate (ECAR) is not well understood. In the present study, we aimed to investigate the effect of HIV 
infection or HIV-1 gp120 protein with cocaine exposure in neuropathogenesis underlining energy deficits and 
metabolic dysfunction as important mechanism in the process. We highlight the role of energy sensor AMPKs 
and mitochondrial biogenesis with subsequent impact of epigenetic remodeling on the complex SWI/SNF which 
may have potential role in progression to neuroAIDS.
Results
Cocaine enhances HIV-1 gp120 induced OCR/ECAR. Studies have shown that HIV positive subjects 
who have used illicit drugs are more sensitive to neuropathogenesis than either substance abusers or HIV infec-
tion alone5,6,34. In this study, we have investigated the interaction of HIV-1 gp120 protein with cocaine exposure 
on the metabolic resources of OCR and ATP–utilization, and their subsequent interaction with energy sensor 
AMPKs. Furthermore, we studied these interactions in the downstream signaling intermediate in acetyl-coA 
carboxylase (ACC), CDC25B/C, MAP/Tau, Wee1 and oxidative damage of mitochondrial biogenesis, and SWI/
SNF lead neuropathogenesis in CHME-5 cells. Data presented in Fig. 1 shows that effect of HIV-1 gp120 is signif-
icantly enhanced by cocaine when measured for ATP concentration (A), measurements of oxygen consumption 
(OCR) (B), extracellular acidification rates (ECAR) (C) and OCR/ECAR ratio (D) in CHME-5 cells. Figure 1A 
shows no changes in utilization of ATP by HIV-1 gp120 exposure whereas cocaine exposure with HIV-1 gp120 
significantly upregulated ATP concentration. Figure 1B shows a significant increase in OCR in cocaine treated 
Figure 1. HIV-1 gp120 protein and cocaine exposure impact ATP utilization, oxygen consumption and 
extracellular acidification in microglia. CHME-5 (10,000 cells/ml) were treated with HIV-1 gp120 (0–100 ng), 
cocaine (0.5 μ M) and combination of HIV-1 gp120 with cocaine for 24 h. Controls were maintained by drug free 
medium. At the end of the incubation period; the OCR and ECAR were measured by Seahorse Bioscience-XF96 
extracellular flux analyzer. Data presented is the average of three independent experiments conducted under the 
same experimental conditions.
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(p < 0.02) and cocaine co-treated with HIV-1 gp120 (p < 0.01) compared to control. Since altered OCR level 
might affect ATP utilization it may play a role in OXPHOS. Therefore, we examined whether ATP utilization 
affects metabolic ratio of OCR/ECAR. Figure 1D results indicate that cells exposed with cocaine and HIV-1 gp120 
(p < 0.02) have a significantly lower OCR/ECAR ratio compared to control.
HIV and cocaine interactive effect on energy sensor AMPKs and epigenetic remodeling complex 
SWI/SNF expression. Figure 2 shows HIV infection is significantly accelerated by cocaine as monitored by 
measuring p24 levels (A), LTR (B), AMPK-α (C) and SWI/SNF (D) expression in CHME-5 cells. Data presented 
in Fig. 2A show that cocaine exposure with HIV infection have significantly increased p24 levels (p < 0.001) 
compared to HIV infection alone. The level of LTR in HIV-infected cells in the presence of cocaine is significantly 
higher than the HIV infected cells (Fig. 2B). Since increased HIV-LTR levels might results in modulation of 
intracellular AMPK expression and it may impact epigenetic function, we analyzed the AMPK-α and epigenetic 
remodeling complex SWI/SNF expression level during HIV infection and cocaine exposure. Figure. 2C shows 
AMPK-α is significantly upregulated by cocaine (p < 0.003), HIV-infection (p < 0.004) and cocaine exposure 
with HIV infection (p < 0.005). Figure. 2D represents the expression level of SWI/SNF in cocaine (p < 0.004), 
HIV-infection (p < 0.002) and cocaine with HIV infection (p < 0.004), respectively.
In addition, we have also studied HIV-1 gp120 protein with cocaine which resulted in the level of ROS pro-
duction, AMPK-α , MAP/Tau, Wee1 and SWI/SNF gene expression. Figure 3A indicates that the level of ROS in 
HIV-1 gp120 with cocaine is significantly increased (P < 0.0003) when compared to either cocaine (p < 0.01) 
or HIV-1gp120 (P < 0.003) alone. Figure. 3B shows AMPK is significantly increased in cocaine (p < 0.05), 
HIV-infection (p < 0.01) and cocaine with HIV infection (p < 0.001). Figure. 3C shows MAP/Tau is also sig-
nificantly upregulated due to cocaine (p < 0.007), HIV-infection (p < 0.001) and cocaine with HIV infection 
(p < 0.005). The transcriptional factor Wee1 and SWI/SNF expression are significantly upregulated during 
cocaine with HIV infection/gp120 protein when compared with control. Expression level of Wee1 during cocaine 
(p < 0.01), HIV-infection (p < 0.001), cocaine exposure with HIV infection (p < 0.01), SWI/SNF expression 
levels due to cocaine (p < 0.02), HIV-infection (p < 0.03) and cocaine exposure with HIV infection (p < 0.02) 
altered significantly. Overall results indicate that HIV infection or HIV-1 gp120 with cocaine significantly upreg-
ulated AMPKs, MAP/Tau, Wee1, and SWI/SNF expression when compared with HIV infection/gp120 protein or 
cocaine alone. These results suggest that HIV infection alters metabolic deficits accelerated by cocaine and it may 
increase viral replication and disease progression.
Cocaine exacerbates HIV-1 gp120 induced protein activation. In order to validate the increased gene 
expression by qRT-PCR, we also investigated their protein expression by western blot analysis (Fig. 4). The immune 
blots shows expression of AMPK-α (A), AMPK- β (B), P-ACC (C), CDC25B (D), CDC25C (E), MAP/Tau (F) and 
Wee1 (G) with the exposure of cocaine, HIV-1 gp120 and cocaine with HIV-1 gp120. The corresponding densitom-
etry analysis was represented in Fig. 4 AMPK-α (H) (p < 0.0001), AMPK-β (I) (p < 0.05), ACC (J) (p < 0.0001), 
CDC25B (K) (p < 0.001), CDC25C (L) (p < 0.001), MAP/Tau (M) (p < 0.001), and Wee1 (N) (p < 0.0001) 
respectively.
Cocaine and HIV-1 gp120 effect on BRSKs Protein. Observed results demonstrated that there was a 
significant upregulation of AMPKs expression in cocaine with HIV infection/HIV-1 gp120 protein when com-
pared to either cocaine or HIV infection/HIV-1 gp120 protein alone. Since BRSK(s) belong to AMPKs families 
and it may be affected by HIV and cocaine. It is important to measure BRSKs expression. Therefore, we have 
Figure 2. Effects of HIV infection and cocaine co-morbidity impact energy sensor AMPK and epigenetic 
remodeling complex SWI/SNF in microglia. CHME-5 (50 × 105 cells/ml) were infected with the HIV Bal 
strain TCID50 for 18 hours. After that, treated with cocaine (0.5 μ M) at every 72 h and the supernatants were 
collected at 7th day and used to estimate p24 antigen by ELISA (A) and infected cells total RNA was extracted 
and reverse transcribed followed by quantitative real time PCR for LTR (B), AMPK-α (C) and SWI/SNF-1 
expression (D). Data are expressed as mean ± SE of TAI values of three independent experiments conducted 
under the same experimental conditions.
www.nature.com/scientificreports/
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analyzed the effect of cocaine and HIV-1 gp120 protein on BRSKs expression which has two isoforms. Data presented 
in Fig. 5 shows BRSK1 expression level in CNS cells such as microglia, astrocyte, neuron and brain microvascular 
endothelial cells (BMVEC) (A). Figure. 5B,C demonstrate BRSK expression in CHME-5 microglial exposed to cocaine, 
HIV-1 gp120 and cocaine with HIV-1 gp120 compared with control. Interestingly, BRSK1 (B) and BRSK2 (C) expres-
sion levels are not affected by either cocaine or HIV-1 gp120 protein. These results suggest that, HIV or cocaine expo-
sure disrupt AMPKs metabolic resources of energy consumption and utilization without affecting BRSKs proteins, 
which leads to dysregulation of downstream signals MAP/Tau and Wee1 transcriptional function.
Cocaine and HIV-1 gp120 effect on mitochondrial biogenesis. Mitochondria plays a prominent role in 
production of energy source (ATP) of cells through respiration and maintenance of cellular function. Once mitochon-
dria is altered, AMPKs expression subsequently affect OXPHOS. Mitochondria were isolated and analyzed by Western 
blot to determine whether AMPKs impact energy deficit and ATP utilization to induce mitochondrial oxidative dam-
age. Figure. 5D shows that CHME-5 cells treated with HIV-1 gp120 had no effect on mitochondria whereas cocaine 
significantly inhibit OXPHOS and affect mitochondrial biogenesis. Interestingly, HIV-1 gp120 had no effect on mito-
chondrial protein but cocaine exposure (p < 0.0001) and cocaine with HIV-1 gp120 (p < 0.01) had significant effect on 
mitochondrial ATP synthase or complex V (CV-ATPase) (Fig. 5E). The ubiquinol–cytochrome c reductase core protein 
II (UQCRC2) of complex III (CIII-UQCRC2) (Fig. 5F) and succinate dehydrogenase (ubiquinone) iron–sulfur subunit 
(SDHB) of complex II (CII-SDHB) (Fig. 5G) significantly inhibits OXPHOS in cocaine with HIV-1 gp120 compared 
with either cocaine or HIV-1 gp120 alone. This suggest that inhibition of CIII-UQCRC2 and CII-SDHB affects mito-
chondrial respiration, which could enhance viral replication and disease progression.
Cocaine and HIV-1 gp120 effect on epigenetics remodeling complex SWI/SNF. Furthermore, the 
liver kinase B1 (LKB1)-AMPKs localize not only to the cytoplasm but also to the nucleus, suggesting a possible 
nuclear role for the interaction and activation of brahma-related gene-1 (BRG1), a catalytic subunit of SWI/SNF 
chromatin remodeling complex35. Therefore, to see any effect SWI/SNF complex protein, we have infected cells with 
HIV virus (Bal) or HIV-1 gp120 protein, in the presence or absence of cocaine exposure. Figure 6 showed SWI/SNF 
protein AT-rich interactive domain-containing protein (ARID1A) expression in HIV-1 gp120 with cocaine (Fig. 6A) 
and HIV infection with cocaine (Fig. 6B) which were significantly upregulated when compared with control. Figure 
6(C,D) shows the densitometry analysis of ARID1A expression in the presence of HIV-1 gp120 protein and HIV 
infection indicating significant upregulation during cocaine (p < 0.05), HIV-1 gp120 (p < 0.01) and HIV-1 gp120 
with cocaine (p < 0.001), and HIV infection (p < 0.01) and cocaine with HIV infection (p < 0.001). The observed 
results of energy sensor AMPKs proteins oxidative damage of mitochondrial biogenesis subsequently upregulate 
SWI/SNF complex in cocaine with HIV infection compared to either cocaine or HIV infection alone.
Discussion
Epidemiological and clinical studies have demonstrated that illicit drugs accelerate viral replication and disease 
progression, which synergistically impair neuronal functions in HIV positive subjects36–39. Studies have also 
shown that cocaine exacerbates HIV infection implicating neuro-immune dysfunction in in vitro as well as HIV 
positive subjects4,5,7. Glial cells are the major resource of energy storage and maintenance of cellular homeostats 
in CNS. These metabolic functions in energy consumption and utilization are regulated by AMPKs17,19,20 and 
also involved in cell architecture, cell polarity and ion transport control40. However, activation of AMPKs lead 
to higher ROS, and subsequently increase AMP: ATP ratio, which might play a vital role in ATP depletion and 
mitochondrial damage leading to neuronal dysfunction41. It is known that microglia is the major reservoir of HIV 
infection and disease progression1,2; and these cells transfer energy to neurons. However, there are no reports on 
Figure 3. Effects of HIV-1 gp120 protein and cocaine co-morbidity induced oxidative stress altered energy 
sensor AMPK and epigenetic remodeling complex SWI/SNF in microglia. CHME-5 (1 × 106 cells/ml) were 
treated with HIV-1 gp120 (50 ng), cocaine (0.5 μ M) and combination of HIV-1 gp120 with cocaine for 24 h. 
Controls were maintained by drug free medium. At the end of the incubation, ROS production was analyzed 
by flow cytometry (A), the total RNA was extracted and reverse transcribed followed by quantitative real time 
PCR for AMPK-α (B), MAP/Tau (C), Wee1 (D) and SWI/SNF-1 (E) and housekeeping β -actin specific primers. 
Data are expressed as mean ± SE of TAI values of three independent experiments conducted under the same 
experimental conditions.
www.nature.com/scientificreports/
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the effects of HIV infection and cocaine-induced metabolic dysfunction and energy impairment which affect 
energy sensor AMPKs, mitochondrial biogenesis and chromatin remodeling complex SWI/SNF. Interestingly, 
Figure 4. HIV-1 gp120 and cocaine impacts AMPK signaling network. CHME-5 (1 × 106 cells/ml) were 
treated with HIV-1 gp120 (50 ng), cocaine (0.5 μ M) and combination of HIV-1 gp120 with cocaine for 24 h. 
Controls were maintained by drug free medium. At the end of the incubation, equal amount of protein lysate 
were resolved by 4–15% SDS-PAGE and protein expression were analyzed by Western blot showing AMPK-α 
(A), AMPK-β (B), P-ACC (C), CDC25B (D), CDC25C (E), MAP/Tau (F) and WEE1 (G). (H–N) represent 
% densitometric values of protein levels (% control), respectively. Data are expressed as mean ± SE of three 
independent experiments conducted under the same experimental conditions.
www.nature.com/scientificreports/
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Figure 5. Effect on BRSKs and oxidative damage on mitochondrial proteins. CHME-5 (1 × 106 cells/ml) 
were treated with HIV-1 gp120 (50 ng), cocaine (0.5 μ M) and combination of HIV-1 gp120 with cocaine for 
24 h. Controls were maintained by drug free medium. At the end of the incubation, equal amount of protein 
lysate were resolved by 4–15% SDS-PAGE and protein expression were analyzed by Western blot showing 
neuronal cells level in BRSK1 (A), and CHEM-5 cells in BRSK 1 (B), BRSK-2 (C), and mitochondrial proteins 
(D).  (E–G) represent % densitometric values of CV-ATPase, CIII-UQCRC2 and CII-SDHB protein levels  
(% control). Data are expressed as mean ± SE of three independent experiments conducted under the same 
experimental conditions.
Figure 6. HIV infection and HIV-1 gp120 co-morbidity with cocaine effect on epigenetics remodeling protein. 
CHEM-5 (1 × 106 cells/ml) were infected with the HIV Bal strain TCID50 for 18 hours. After that, treated with cocaine 
(0.5 μ M) every 72 h. In another set of experiment, CHME-5 (1 × 106 cells/ml) were treated with HIV-1 gp120 (50 ng), 
cocaine (0.5 μ M) and combination of HIV-1 gp120 with cocaine for 24 h. At the end of the incubation, equal amount 
of protein lysate were resolved by 4–15% SDS-PAGE and protein expression were analyzed by Western blot showing 
HIV infected with cocaine effect on SWI/SNF protein ARID1A (A) and HIV-1 gp120 protein with cocaine (B). (C,D) 
represent % densitometric values protein levels (% control), respectively. Data are expressed as mean ± SE of three 
independent experiments conducted under the same experimental conditions.
www.nature.com/scientificreports/
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how HIV infection as well as cocaine exposure impact metabolic dysfunction in independent pathways, which do 
not affect BRSKs are need to be further studied. The observed results provide new insights into the functional role 
of AMPKs expression altered mitochondrial biogenesis which subsequently affect epigenetic remodeling complex 
SWI/SNF. HIV infection and cocaine interaction are known to induces oxidative stress and ROS production7,42, 
and it may activate energy sensor AMPKs, mitochondrial biogenesis and subsequently impact downstream sig-
nals for CDC25B, CDC25C, MAP/Tau, Wee1 and SWI/SNF transcription, which may play a vital role in neuronal 
dysfunction in HIV associated neurocognitive disorder (HAND).
In the present study, we have shown for the first time that cocaine with HIV infection or HIV-1 gp120 protein 
impact additively the of ATP utilization, ECR/OCAR ratio (Fig. 1), ROS production and activation of AMPKs, and 
CDC25B, CDC25C, MAP/Tau and Wee1 expression (Figs 2 and 3) associated with inhibition of mitochondrial 
oxidative phosphorylation. The increase in AMPKs expression subsequently upregulates Wee1 and SWI/SNF tran-
scription, which may enhances viral replication and disease progression. These results suggest that cocaine acceler-
ates HIV infection as well as HIV-1 gp120 protein may have an enhanced role on AMPKs and SWI/SNF complex 
when compared to control. This is consistent with earlier reports of HIV infection impacting AMP: ATP ratio and 
utilization of energy metabolites and leading to AMPKs and SWI/SNF pathways43,44. The BRSKs and SNARK pro-
teins are closely associated with energy metabolic role45 and act as a checkpoint kinase, as it phosphorylate Wee1 
and CDC25B/C, and regulates neuronal polarization24. Studies have also shown that HIV-1 gp120 and Vpr activate 
CDC25B/C mediated cell cycle arrest, which may lead to adult neurogenesis and dementia46. However, recently 
we have also shown that HIV-1 gp120 with morphine significantly accelerates the expression of CDC25B/C and 
tentatively impact cell cycle process47. These findings are consistent with our present observation on MAP/Tau and 
CDC25B/C which are involved in energy deficits leading to neuropathogenesis (Fig. 4).
Two other AMPK-related kinases, BRSKs proteins (BRSK1 and BRSK2), are also highly expressed in the mam-
malian brain and are crucial for neuronal development. We have also analyzed BRSKs expression in CNS cells 
(primary astrocytes and BMVEC, and SK-N-MC neuroblastomas) and these kinases are predominantly found in 
all these cells (Fig. 5). Interestingly, BRSKs (BRSK1 and BRSK2) are not affected by either HIV-1 gp120 or cocaine 
exposure in microglia (Fig. 5B,C). It is known that BRSKs play a wide role in CNS especially in neuronal polarity 
whereas no studies have reported yet in glial cells. In this present study we have tried to find out whether these 
kinases are involved in any metabolic network in microglia. Surprisingly, these proteins are not involved in either 
HIV or cocaine impact on metabolic ratio suggesting that it may work on an independent pathway regulating 
without affecting BRSKs. Studies have also shown that AMPK and BRSK regulate neuronal polarization and 
vesicular transmission in neuron22. Interestingly, AMPKs without affecting BRSKs induce neurodegeneration 
which will be a novel pathway and its functions are reaming unknown.
Besides, oxidative stress and ROS production inhibit redox expression and affect mitochondrial biogenesis and 
oxidative phosphorylation which are known to regulate post-translational modifications induced by the energy 
sensors, AMPK48. Also, mitochondrial dysfunction is associated with the pathogenesis of several neurodegenera-
tive diseases, including AD49 and PD50. Studies have shown that mitochondrial dysfunction plays a critical role in 
the pathologic mechanisms of neurologic disorders and associated with the drugs of abuse and HIV infection51,52. 
Dysfunctional mitochondrial machinery induces the disruption of energy metabolism that culminates with a 
decrease in ATP production, Ca2+ buffering impairment and exacerbated generation of ROS53. Whereas brain 
mitochondrial dysfunction is an important component of neurodegeneration, and significant disruption of mito-
chondrial respiration49,54. These observed results suggest that increased ATP utilization subsequently shutdown 
the energy consumption pathway and inhibit mitochondrial OXPHOS which could possibly be at least partially 
responsible for the energy dysfunction effects (Fig. 5D,E). Studies have also shown that cocaine induced oxidative 
stress impact brain mitochondrial function and energy metabolism in cocaine abusers55, and HIV positives56. 
Defective OXPHOS may be caused by abnormal mitochondrial biosynthesis due to inherited or acquired muta-
tions in the nuclear (n) or mitochondrial (mt) deoxyribonucleic acid (DNA). It is know that OXPHOS inhibiting 
CV-ATPase and CIII-UQCRC2, and CII-SDHB play a vital role in induction of mitochondrial DNA.
Epigenetics remodeling complex SWI/SNF is a CDK5, a cell cycle protein and it may play role in energy 
deficits leading to cell cycle arrest. However, the mammalian SWI/SNF chromatin-remodeling complex plays an 
essential roles in a variety of cellular processes including differentiation, proliferation and DNA repair, which are 
altered by mitochondrial biogenesis. These functions are ATP-dependent, which use energy from ATP hydrolysis 
to disrupt energy production and utilization interactions, containing one of two catalytic ATPase subunits, called 
Brm and Brg1. Both Brg1 and Brm have been implicated in transcriptional activation and repression28. Several 
SWI/SNF-related factors have been implicated in transcriptional silencing through cell cycle arrest22. These stud-
ies further confirm that the downstream cascade CDC25B/C, wee1, and SNF/SWI are upregulated in cocaine 
along with HIV-1 gp120 exposure leading to cell cycle arrest. However, CDC25B/C are direct targets of CDK557, 
which may be mediated by CDC25B/C leading to neuronal impairment. Supporting our hypothesis, recent stud-
ies have demonstrated that the Brg-1, a CDK5, results on neuronal impairments including plasticity and memory 
dysfunction27,58. These results confirm that increased AMP: ATP utilization and activation of AMPKs exacerbate 
the viral replication and disease progression in cocaine use during HIV infection.
Further, our results show that cocaine treatment, HIV infection, and HIV-1 gp120 protein cause an induc-
tion of SWI/SNF protein ARID1A expression (Fig. 6). ARID1A is a member of the SWI/SNF family and is a 
unique component of the BRG1, whose members have helicase and ATPase activities and are thought to regulate 
transcription of certain genes by altering the chromatin structure around those genes. The main observation in 
this report is that HIV infection or HIV-1gp120 protein with cocaine have upregulated AMPKs activation and 
subsequently inhibit mitochondrial OXPHOS, which leads to increase in the expression level of MAP/Tau and 
SWI/SNF protein ARID1A (Fig. 7). However, HIV-1 along with cocaine exposure has significantly upregulated 
SWI/SNF complex and ARID1A protein which is associated with a concomitant activation of ATP utilization and 
AMPKs activation. Studies have shown that contractual report on ARID1A expression, however, over expression 
www.nature.com/scientificreports/
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of ARID1A impairs liver proliferation and regeneration59. These results suggest that there is an interactive role 
between cocaine and HIV that additively potentiate and increase co-morbidity when compared to either cocaine 
or HIV infection alone.
Overall, the data provides evidence in the interaction of cocaine with HIV infection and gp120 protein induc-
tion which is associated with activation of AMPKs and subsequently affects energy sources. Based on these 
results, we have demonstrated that energy deficits potentiate HIV viral replication and disease progression by 
impairing the glial function, which may lead to neurodegeneration. The present study support some of earlier 
reports in the dysfunction of energy resources60 and increased neurodegeneration in cocaine using HIV-1 Tat 
protein61,62. These observations lead to demonstrate that energy sensor AMPKs, mitochondrial biogenesis and 
chromatin remodeling complex SWI/SNF plays a major role and contributes in viral replication and disease 
progression in cocaine abusers. These findings provide a novel pathway to explain neurological deficits in neuro-
pathogenesis associated with cocaine exposure during HIV infection.
Methods
HIV virus and gp120 proteins. The HIV-1 Bal strain and recombinant gp120 (Bal) proteins were obtained 
from the NIH AIDS Research and Reference Reagent Program. The recombinant HIV-1 gp120 proteins were 
>95% purity.
Figure 7. Schematic pathway of HIV infection and cocaine impact on microglial energy resource and 
influence neuronal toxicity. A comprehensive model showing how HIV-gp120 and cocaine effect energy sensor 
AMPKs signaling mechanism and epigenetic signature lead neurotoxicity. HIV infection and HIV envelop 
protein (gp120) leads to altered AMP/ATP ratio and AMPKs activations’ which influence mitochondrial 
biogenesis and subsequent induction of MAP/Tau and CDC25B/C mediated epigenetic remodeling SWI/SNF 
complex, and that may lead neurotoxicity.
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Cell cultures. In this study, we used immortalized CHME-5 microglial cells, primary astrocytes, BMVC and 
SK-N-MC neuroblastoma cell lines. Primary cells astrocytes and BMVC were maintained in basal medium con-
taining 10% fetal bovine serum, 50 units/ml of penicillin, with growth supplement, and 100 μ g/ml of streptomycin 
(Sciencell, Carlsbad,CA). The neuroblastoma cell line, SK-N-MC was purchased from ATCC (catalog # HTB-
10;Manassas, VA) and the immortalized CHME-5 microglial cells were cultured in Eagle’s minimum essential 
medium (MEM) supplemented with fetal bovine serum to a final concentration of 10% and 1% antibiotic ⁄ anti-
mycotic solution (Sigma-Aldrich, St. Louis, MO).
Measurements of oxygen consumption and extracellular acidification. Oxygen consumption rate 
(OCR) and extracellular acidification rate (ECAR) was measured using XF96 extracellular flux analyzer (Seahorse 
Bioscience, North Billerica, MA)63. CHME-5 (10,000 cells/well) were incubated at 37 °C/10% CO2 incubator for 
24 h in 96 cell culture plate. After 24 h, growth medium was exchanged with XF assay medium (DMEM supple-
mented with 25 mM glucose, 4 mM L-glutamine and 1 mM pyruvate with low phosphate and without bicarbo-
nate). Cells were treated with increasing concentration of HIV-1 gp120 protein (0–100 ng/ml) with or without 
cocaine (0.5 μ M) at 24 hr. End of the incubation period; the OCR and ECAR were measured and expressed as 
percentage.
HIV virus infection and gp120 protein treatment. CHME-5 (50 × 105 cells/ml) were treated with poly-
brene (4 μ g/ml) for 5 hours and then infected with HIV-1 Bal at 20 ng/106 or TCID50 at 37 °C. After 18 hours, 
the cells were washed with PBS, and the HIV infections were maintained for 7 days as previously described64. 
CHME-5 (1 × 106 cells/ml) was treated with HIV-1 gp120 protein (50 ng/ml) for 24 h. The untreated cells served 
as the negative control.
RNA extraction and real-time quantitative PCR (qRT-PCR). Total RNA from CHME-5 microglial 
cells was extracted using a Qiagen kit (Invitrogen Life Technologies, CA, USA) followed by cDNA synthesis using 
the high capacity reverse transcriptase cDNA kit (Applied Biosystems, Foster City, CA) to perform qRT-PCR using 
Taqman gene expression assays (Applied Biosystems, Foster City, CA) for LTR, AMPKs (α and β ), MAP/Tau, 
Wee1 and SWI/SNF were normalized to β -actin housekeeping gene65. The relative abundance of each mRNA 
species was assessed using the brilliant Q-PCR master mix from Applied Biosystems and the Stratagene Mx3000P 
instrument, which detects and plots the increase in fluorescence versus the PCR cycle number to produce a con-
tinuous measure of PCR amplification. Relative expression was quantitated for each mRNA species, and the mean 
fold change in the expression of the target gene was calculated using the comparative CT method (Transcript 
Accumulation Index, TAI = 2−ΔΔCT). All data were controlled for the quantity of RNA input by performing meas-
urements on the endogenous reference gene β -actin. In addition, RNA results from treated samples were normal-
ized to results obtained using RNA from the control, untreated sample.
Mitochondria Isolation. Mitochondrial Isolation Kit (Abcam, CA) was used to isolate mitrochondria from 
the treated cells Briefly, CHME-5 (3 × 108) cells were grown and treated with HIV-1 gp120 (50 ng/ml) and cocaine 
(0.5 μ M) at 24 h. End of the incubation, cells were split by 0.05% trypsin-EDTA and washed with PBS. The cells 
were pelleted by centrifugation (1000 × g for 15 min) at room temperature and suspended in mitochondrial 
assay buffer. Cells were incubated in the solution on ice for 2 min. CHME-5 cells were homogenized with a glass 
homogenizer using 10 up-down strokes, and cellular disruption was confirmed by microscopy. That supernatant 
was centrifuged at 5,000 × g for 10 min at 4 °C according manufactures protocol. The pellet was then resuspended 
in lysis buffer (Pierce, Rockford, IL) for Western blot analysis.
Western blot analysis. To assess modifications of AMPKs, ACC, (Cell signaling, CA), BRSKs, CDC25B, 
CDC25C, MAP/Tau, Wee1 (Santa Cruz Biotechnologies, CA) and SWI/SNF protein ARID1A (Novus Biological 
Lab, Littleton, CO) in CHME-5 by treating with HIV-1 gp120 alone or in combination with cocaine, the cells were 
lysed using lysis buffer (Pierce, Rockford, IL, USA) with protease inhibitor cocktail. Equal amounts of total cellu-
lar proteins were resolved using 4–15% gradient polyacrylamide gel electrophoresis, transferred to a nitrocellu-
lose membrane and incubated with respective primary antibodies (1:1000) for overnight and washed with TBST 
buffer and incubated respective secondary antibodies. Immunoreactive bands were visualized using a chemilumi-
nescence western blotting system according to the manufacturer instructions (Amersham).
Determination of Reactive Oxygen Species (ROS) production. The HIV-1 gp120 and cocaine 
induced ROS production were analyzed using flow cytometry in FACS caliber (BD Bioscience, San Jose, CA). 
Briefly, CHME-5 cells (5 × 105) were treated HIV-1 gp120 with or without cocaine for 24 h. At the end of the time 
period, 2,7-dichlorodihydrofluorescein diacetate (10 μ M) (DCFH-DA) (Invitrogen, Carlsbed, CA) was added to 
the medium and incubated at 37 °C for 30 min followed by washing with PBS then ROS production levels were 
analyzed.
ELISA - p24 measurements. A commercially available enzyme linked immunosorbent assay (ELISA) kit 
(Zeptometrix, Buffalo, NY, USA) was used to quantitate p24 in culture supernatants.
Data analysis. Results presented in this study are representative of three or more independent experiments 
performed in triplicate. Statistical significance was analyzed using Graph Pad Prism5 software, La Jolla, CA by 
performing ANOVA or the Student’s t-test for unpaired observations. The values are presented as means ± SEM, 
and P < 0.05 was considered to be significant.
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